treatment-resistant depression - Search News

FDA approves Johnson & Johnson's nasal spray for depression

Hosted on MSN · 15m

FDA Clears Spravato For Monotherapy Depression Treatments

The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of depression, officials said. The FDA granted approval to Spravato (esketamine) as the first monotherapy for adults with treatment-resistant depression,

Fox Business · 18h

J&J's ketamine-derived nasal spray approved by FDA to treat depression

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

FDA Approves Esketamine Nasal Spray for Treatment-Resistant Depression

The FDA has approved esketamine (Spravato) nasal spray as a monotherapy for adults with treatment-resistant depression. This approval applies to individuals who have had an inadequate response

Psychology Today3d

New Strategies for Treatment-Resistant Depression

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

Inquirer on MSN1d

Ketamine a lifeline for severe depression patients in Singapore

Ketamine, the controlled drug best known as a horse tranquilizer or party supplement, has in the last four years become a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results